Cargando…
Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis
As a tumor suppressor gene, 14-3-3 σ has been reported to be frequently methylated in breast cancer. However, the clinical effect of 14-3-3 σ promoter methylation remains to be verified. This study was performed to assess the clinicopathological significance and diagnostic value of 14-3-3 σ promoter...
Autores principales: | Ye, Meng, Huang, Tao, Ying, Ying, Li, Jinyun, Yang, Ping, Ni, Chao, Zhou, Chongchang, Chen, Si |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354727/ https://www.ncbi.nlm.nih.gov/pubmed/27999208 http://dx.doi.org/10.18632/oncotarget.13992 |
Ejemplares similares
-
Methylation of 14-3-3σ gene and prognostic significance of 14-3-3σ expression in non-small cell lung cancer
por: Raungrut, Pritsana, et al.
Publicado: (2017) -
Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines
por: Ye, Meng, et al.
Publicado: (2017) -
The σ(70) family of sigma factors
por: Paget, Mark SB, et al.
Publicado: (2003) -
Methylated claudin-11 associated with metastasis and poor survival of colorectal cancer
por: Li, Jinyun, et al.
Publicado: (2017) -
The 14-3-3σ gene promoter is methylated in both human melanocytes and melanoma
por: Liu, Suhu, et al.
Publicado: (2009)